![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 41, 37967-37973, October 12, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
, and
From the The microtubule-associated protein
tau is a family of six isoforms that becomes abnormally
hyperphosphorylated and accumulates in neurons undergoing
neurodegeneration in the brains of patients with Alzheimer disease
(AD). We investigated the isoform-specific interaction of normal tau
with AD hyperphosphorylated tau (AD P-tau). We found that the binding
of AD P-tau to normal human recombinant tau was
New York State Institute for Basic Research
in Developmental Disabilities, Staten Island, New York 10314, ¶ Departmento de Química Biológica, Facultad de
Ciencias Químicas, Centro de Investigaciones en Química
Biológica de Córdoba-CONICET, Córdoba 5000, Argentina, and § Institute of Neuroimmunology, Slovak
Academy of Sciences, Dubrovdka cesta 9, Bratislava 842 46, Slovak Republic
4L >
4S >
4 and
3L >
3S >
3, and
that its binding to
4L was greater than to
3L. AD P-tau also
inhibited the assembly of microtubules promoted by each tau isoform and caused disassembly when added to preassembled microtubules. This inhibition and depolymerization of microtubules by the AD P-tau corresponded directly to the degree of its interaction with the different tau isoforms. In vitro hyperphosphorylation of
recombinant tau (P-tau) conferred AD P-tau-like characteristics. Like
AD P-tau, P-tau interacted with and sequestered normal tau and
inhibited microtubule assembly. These studies suggest that the AD P-tau interacts preferentially with the tau isoforms that have the
amino-terminal inserts and four microtubule binding domain
repeats and that hyperphosphorylation of tau appears to be sufficient
to acquire AD P-tau characteristics. Thus, lack of amino-terminal
inserts and extra microtubule binding domain repeat in fetal human
brain might be protective from Alzheimer's neurofibrillary degeneration.
To whom correspondence should be addressed: New York State
Institute for Basic Research in Developmental Disabilities, 1050 Forest
Hill Rd., Staten Island, NY 10314. Tel.: 718-494-5259; Fax:
718-494-1080; E-mail: kiqbal@admin.con2.com.
This article has been cited by other articles:
![]() |
D. P. Hanger, H. L. Byers, S. Wray, K.-Y. Leung, M. J. Saxton, A. Seereeram, C. H. Reynolds, M. A. Ward, and B. H. Anderton Novel Phosphorylation Sites in Tau from Alzheimer Brain Support a Role for Casein Kinase 1 in Disease Pathogenesis J. Biol. Chem., August 10, 2007; 282(32): 23645 - 23654. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Liu, K. Iqbal, I. Grundke-Iqbal, S. Rossie, and C.-X. Gong Dephosphorylation of Tau by Protein Phosphatase 5: IMPAIRMENT IN ALZHEIMER'S DISEASE J. Biol. Chem., January 21, 2005; 280(3): 1790 - 1796. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. d. C. Alonso, A. Mederlyova, M. Novak, I. Grundke-Iqbal, and K. Iqbal Promotion of Hyperphosphorylation by Frontotemporal Dementia Tau Mutations J. Biol. Chem., August 13, 2004; 279(33): 34873 - 34881. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Suo, M. Wu, B. A. Citron, R. E. Palazzo, and B. W. Festoff Rapid Tau Aggregation and Delayed Hippocampal Neuronal Death Induced by Persistent Thrombin Signaling J. Biol. Chem., September 26, 2003; 278(39): 37681 - 37689. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |